BEGAIN
Brain-enriched guanylate kinase-associated protein
Also known as: BEGIN_HUMAN, KIAA1446
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUH8
- Gene
- BEGAIN
- Ensembl
- ENSG00000183092
- Chromosome
- 14
- Canonical length
- 593 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
Predicted to enable kinase activity. Predicted to be involved in evoked excitatory postsynaptic potential and regulation of postsynaptic neurotransmitter receptor activity. Predicted to be located in dendrite; nucleus; and presynapse. Predicted to be active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>Q9BUH8|BEGAIN
1 MEKLSALQEQ KGELRKRLSY TTHKLEKLET EFDSTRHYLE IELRRAQEEL EKVTEKLRRI
61 QSNYMALQRI NQELEDKLYR MGQHYEEEKR ALSHEIVALN SHLLEAKVTI DKLSEDNELY
121 RKDCNLAAQL LQCSQTYGRV HKVSELPSDF QERVSLHMEK HGCSLPSPLC HPAYADSVPT
181 CVIAKVLEKP DPASLSSRLS DASARDLAFC DGVEKPGPRP PYKGDIYCSD TALYCPEERR
241 RDRRPSVDAP VTDVGFLRAQ NSTDSAAEEE EEAEAAAFPA GFQHEAFPSY AGSLPTSSSY
301 SSFSATSEEK EHAQASTLTA SQQAIYLNSR DELFDRKPPA TTYEGSPRFA KATAAVAAPL
361 EAEVAPGFGR TMSPYPAETF RFPASPGPQQ ALMPPNLWSL RAKPGTARLP GEDMRGQWRP
421 LSVEDIGAYS YPVSAAGRAS PCSFSERYYG GAGGSPGKKA DGRASPLYAS YKADSFSEGD
481 DLSQGHLAEP CFLRAGGDLS LSPGRSADPL PGYAPSEGGD GDRLGVQLCG TASSPEPEQG
541 SRDSLEPSSM EASPEMHPAA RLSPQQAFPR TGGSGLSRKD SLTKAQLYGT LLNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BEGAIN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 54 nTPM
- cerebral cortex: 43 nTPM
- amygdala: 37 nTPM
- hippocampal formation: 37 nTPM
- basal ganglia: 24 nTPM
- pancreas: 23 nTPM
Single-cell type
- retinal horizontal cells: 319 nCPM
- early spermatids: 37 nCPM
- thyrotrophs: 36 nCPM
- gonadotrophs: 35 nCPM
- brain excitatory neurons: 31 nCPM
- mast cells: 31 nCPM
Immune cell
- eosinophil: 2.8 nTPM
- basophil: 0.8 nTPM
- intermediate monocyte: 0.6 nTPM
- non-classical monocyte: 0.5 nTPM
- plasmacytoid DC: 0.4 nTPM
- neutrophil: 0.2 nTPM
Brain region
- hippocampal formation: 47 nTPM
- cerebral cortex: 44 nTPM
- amygdala: 36 nTPM
- cerebellum: 36 nTPM
- basal ganglia: 36 nTPM
- white matter: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- evoked excitatory postsynaptic potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BEGAIN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BEGAIN as an antibody target. Whether an autoantibody or antibody against BEGAIN could matter depends on whether native BEGAIN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BEGAIN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BEGAIN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...